ITGA2B and neoplasm: Recent studies have demonstrated that the transfer of CD41 from PEVs to tumor cells stimulates the activation of the MAPK-p42/44 and AKT signalling pathways, as well as the upregulation of MMPs necessary for ECM remodelling and invasion (155).